ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Key Considerations When Filling Dual Chamber Syringes

  Dual-chamber syringes (DCSs) are in high demand across the pharmaceutical and hospital industries. Learn about the challenges of the DCS filling manufacturing market and how to overcome them.

• Meeting The Growing Demand For Pre-Filled Syringes

  The market for pre-filled syringes is growing rapidly. Learn more about the benefits for consumers, providers, and manufacturers, and the importance of partnering with a reliable fill finish facility.

• How Devices, Instructions, And Packaging Work Together To Improve Safety

  A medical device's user interface is the entire product system: the device, labeling, packaging, and IFU. These elements are crucial for risk mitigation and must be tested holistically.

• The Future Of CDMOs: Aseptic Filling Solutions For Growth And Innovation

  The rapid rise of highly targeted cell and gene treatments requiring small batch production necessitates a new path forward for biologics manufacturing and directly impacts the CMO/CDMO landscape.

• Utilizing Robotic Aseptic Filling Systems To Meet Industry Needs

  An aseptic filling and closing machine solution allowed Catalent to reliably process a wide range of both trayed and nested vials for their client product needs.

• Liposomes — Challenges And Opportunities

  Liposome technology is an effective drug delivery tool but still presents difficulties. Learn how developers are meeting these challenges and the opportunities for advancement to maximize liposome usefulness.

• 3D Printing Of Pharmaceutical Dosage Forms – Has The Time Come?

  Additive manufacturing, or 3D printing, is arguably balancing on the cusp of translation from academic research into industry practice for pharmaceuticals. What will the future impact of 3D printing be?

• Ready-To-Use Cartridges: Ensuring Compatibility For GLP-1-Based Drugs

  Ready-to-use cartridges for GLP-1 applications offer safe, reliable self-administration. See how they can minimize complexities and better align with the stringent demands of modern manufacturing.

• Improved Bioavailability In 12 Weeks

  A lead compound showed clinical promise but had limited bioavailability owing to low solubility. Learn about the challenges, including the molecular characterization and limited budget, and the structured 3-step approach.

• Guidelines For Selecting A Medical Device Contract Manufacturer

  Consider these guidelines when evaluating potential device contract manufacturers to choose one that will be the best fit for your company.